Programmed cell death

Tiny cells in your body can die.

When you were growing, cells died to make your fingers. This helped the spaces between your fingers form.

This process also helps your brain. Many cells in the brain die to help it work well.

Sometimes cells die because they are hurt. Other times, they die to keep you healthy. This stops cells from growing too much.

It is a very important job for your body. It helps you stay strong and grow.

Cells in your body have a way to die on purpose. We call this programmed cell death. It is a planned set of steps. This process helps living things grow.

One way this happens is called apoptosis. In apoptosis, a cell follows a genetic plan to die. This can happen for two reasons. One way is through the extrinsic pathway. This happens when signals from outside the cell tell it to die. Another way is the intrinsic pathway. This happens inside the cell. It can be caused by damage to the cell's DNA.

Another way is called autophagy. This is when a cell uses its own parts to break things down. It can happen when a cell does not have enough food.

Programmed cell death is very important for your brain. In a growing brain, many cells die to help it work well. This helps make the right connections. It also stops cells from growing too much. This can help prevent diseases like cancer.

Cells in living things have a way to die on purpose. This is called programmed cell death, or PCD. It is a planned set of steps that happens inside a cell. This process is very important for how a body grows and stays healthy. For example, a human embryo develops separate fingers and toes because the cells between them die. Without this planned death, our hands would look very different.

One main way this works is through a process called apoptosis. Apoptosis can start in two different ways. In the extrinsic pathway, signals from outside the cell trigger the death. This often involves special proteins called caspases that act like tiny switches. In the intrinsic pathway, the death starts inside the cell. This can happen if the cell's DNA is damaged by things like UV light. The mitochondria, which are like the cell's power plants, help send this signal.

Scientists have studied these pathways for a long time. The idea of programmed cell death was used in 1964 to describe insect growth. Later, researchers like Durand and Ramsey helped define how it works. A big discovery came from studying a protein called BCL2. Most cancer genes help cells grow too much. However, BCL2 can cause cancer by stopping cells from being able to kill themselves. In 2002, Sydney Brenner, H. Robert Horvitz, and John E. Sulston won a Nobel Prize for their work on this subject.

There are many specific details and numbers in this science. In a growing nervous system, almost 50% of developing neurons are removed by PCD. In humans, this starts in the progenitor cells at gestational week 7. Later, between weeks 19 and 23, it happens to post-mitotic cells. Other types of death exist too, like autophagy. This is when a cell breaks down its own parts, often when it lacks nutrients. There is even a type called necroptosis, which acts as a backup if apoptosis fails.

Understanding PCD helps us understand how our own bodies are built. It is like a construction crew that must remove extra bricks to make a doorway. This process keeps the body in balance, which is called homeostasis. If cells do not die when they should, it can lead to diseases like cancer. By managing which cells live and which die, the body stays organized. This balance is vital for every plant and animal on Earth.

Programmed cell death (PCD) is a controlled biological process where a cell undergoes death due to internal events. This is not a random accident, but a genetically directed sequence of steps. PCD is vital for the growth and survival of multicellular organisms. It allows an organism to shape its body during development and maintain health by removing unnecessary or damaged cells. Without this mechanism, life as we know it could not organize itself correctly.

One primary form of PCD is apoptosis, often called Type I cell death. During apoptosis, a cell undergoes specific physical changes, known as morphology. These changes include cell shrinkage, the condensation of chromatin, and the fragmentation of the nucleus. The cell membrane may also undergo blebbing, which looks like small bubbles forming on the surface. These steps ensure the cell is dismantled in an orderly way. This process is essential for preventing cellular overgrowth, which can lead to diseases like cancer.

Apoptosis can be triggered through two distinct routes: the extrinsic and the intrinsic pathways. The extrinsic pathway begins when external signals bind to specific receptors on the cell membrane. For example, the FAS ligand can bind to the FAS receptor, or the TNF-alpha ligand can bind to the TNF receptor. This interaction activates initiator caspases, which are specialized enzymes that act as molecular switches. In some cases, a cytotoxic T-cell attaches to a target cell and releases granzyme B. This protein creates pores in the membrane, allowing perforin to enter and trigger the caspase cascade.

The intrinsic pathway, by contrast, is triggered by internal damage, such as DNA damage or exposure to UV radiation. This process occurs within the mitochondria, which are the energy-producing organelles of the cell. Sensors called Bcl sensors, along with proteins named BAX and BAK, detect the damage. These proteins pierce the outer mitochondrial membrane to form pores. These pores allow cytochrome c to leak out into the cell. Once cytochrome c is released, it helps form an apoptosome complex. This complex activates executioner caspases that carry out the cell's destruction.

Another major form of PCD is autophagy, or Type II cell death. This is a catabolic process, meaning the cell breaks down its own components. During autophagy, the cell creates large vacuoles that consume damaged organelles and abnormal protein aggregates. This process is often activated by nutrient deprivation to help the cell survive. A key regulator of this process is a kinase called mTOR. When mTOR is active, it suppresses autophagy; when it is inactive, autophagy is promoted. This mechanism helps maintain cellular balance, though excessive autophagy can eventually lead to cell death.

Research into PCD has uncovered many other specialized types of death. Necroptosis is a form of programmed necrosis, which acts as a backup when apoptosis signals are blocked by viruses or mutations. Other types include ferroptosis, which depends on iron, and pyroptosis, an inflammatory death triggered by infections. In the nervous system, PCD plays a massive role in sculpting the brain. In humans, nearly 50% of developing neurons are removed through PCD to optimize connections. This process begins in progenitor cells at gestational week 7 and continues in post-mitotic cells between weeks 19 and 23.

The history of this field is marked by significant scientific breakthroughs. The term "programmed cell death" was used as early as 1964 to describe insect tissue development. Later, scientists like Durand and Ramsey provided clearer evolutionary and mechanistic definitions. A major turning point involved studying the BCL2 protein. While most cancer-related genes promote cell growth, BCL2 can cause cancer by preventing cells from undergoing apoptosis. This discovery helped explain how certain lymphomas develop. In 2002, Sydney Brenner, H. Robert Horvitz, and John E. Sulston were awarded the Nobel Prize in Physiology or Medicine for their fundamental work on these mechanisms.